[Clinical picture of rheumatologic diseases. Current status of cytostatic therapy].
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D001379:Azathioprine / Q000009:adverse effects; D002699:Chlorambucil / Q000009:adverse effects; D003520:Cyclophosphamide / Q000009:adverse effects; D006801:Humans; D007165:Immunosuppression Therapy; D008727:Methotrexate / Q000009:adverse effects; D009369:Neoplasms / Q000139:chemically induced; D010396:Penicillamine / Q000627:therapeutic use; D013997:Time Factors; D014228:Triaziquone / Q000009:adverse effects
D000970:Antineoplastic Agents; D002699:Chlorambucil; D003520:Cyclophosphamide; D014228:Triaziquone; D010396:Penicillamine; D001379:Azathioprine; D008727:Methotrexate
Rheumatologische Krankheitsbilder. Derzeitiger Stand der cystostatischen Therapie